Top 10 Canadian Marijuana and Cannabis Stocks

(A Top Pick Dec 09/19, Up 30%) Still likes this long-term, but he's now focused on U.S. weed names. He prefers other names.

It's been a wild ride. The valuation across all the names are still quite high. With what we are seeing with legislation in the US, he would still tend to look at these. Stick with it.

(A Top Pick Dec 17/20, Up 93.6%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with APHA has triggered its stop at $19. To be disciplined, we recommend covering the position. Combined with the previous recommendation to cover 50%, this will create a net investment return of 59%.

It got stuck above $30 and is now building a nice base. He likes this.

Weed stocks have been enjoying a resurgence after plummeting after Canadian legalization in October 2018. The driver, of course, is American legalization, happening state-by-state but definitely moving forward after the Democrats took the White House last November. While several names are buying candidates, from Canopy to Curaleaf, Hexo has soared 84% so far this year…

(A Top Pick Oct 04/18, Down 87%) A perfect example on staying atop your stocks. He sold around $9.88. Never fund to sell on a loss, and he did and that saved a lot of money.

He is hesitant to look into the social media companies related to the cannabis sector. He does not believe there is enough defensible on the technology side to say data gathering is a beneficial business in this space yet.

Flies under the radar, not top tier because of its size. Tremendous respect for management team. Very efficient, and that's probably why BATS invested. Will be one of the fastest growing sectors in next decade.

This company has a lot of scientific research to support the health care aspects of cannabis. They also have extensive experience in low cost farming economics as part of their partnership with Village Farms (VFF-T).

Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.

Wouldn't buy. Firstly on principle, as they're active managers. The ETF owns the good, the bad, and the ugly. There are a lot of garbagy business models and bottom feeders out there.